CLINICAL_TRIALS
trial_result
· 2015-04-22
Clinical Trial Update: Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD [Phase 4]
Summary
This Phase 4 study completed by Pfizer compared atorvastatin with simvastatin for the prevention of coronary heart disease in patients with known coronary heart…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Cardiovascular Diseases | Phase 4 | Status: COMPLETED